BULENT OZPOLAT to Neoplastic Stem Cells
This is a "connection" page, showing publications BULENT OZPOLAT has written about Neoplastic Stem Cells.
Connection Strength
0.711
-
Pancreatic Cancer Stem Cells and Therapeutic Approaches. Anticancer Res. 2017 06; 37(6):2761-2775.
Score: 0.337
-
Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth. J Cell Mol Med. 2015 Jun; 19(6):1262-72.
Score: 0.289
-
Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen- and doxorubicin-induced autophagy. Int J Mol Med. 2013 Jun; 31(6):1477-83.
Score: 0.063
-
A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer. Pharmacol Res. 2018 03; 129:500-514.
Score: 0.022